Heavy Bio (CEO Yoo Ji-ah Lin) will participate in the ‘6 International Advanced Medical Devices and Medical Industry Exhibition (KOAMEX 30)’ held at EXCO in Daegu for 7 days from Friday, June 2th to Sunday, July 3nd. revealed.
Heavy Bio is a global company that has specialized in handling and supplying high-quality in vitro diagnostic (IVD) solution raw materials since its establishment in 2017, and has specialized capabilities in the development, manufacturing, and sales of antigens and antibodies for IVD reagents. The company explains that it was built around personnel with accumulated expertise in the IVD field.
In particular, Heavy Bio, which has extensive expertise in the fields of recombinant proteins and single antibodies, is conducting business in various IVD application fields such as chemiluminescence, blood coagulation, and lateral flow. We have four antigen and antibody platforms, including prokaryotes, yeast, insect cells, and mammalian cells, and furthermore, we have more than 400 items including major IVD fields such as infectious diseases, tumor biomarkers, cardiac biomarkers, inflammatory biomarkers, endocrinology, and Alzheimer’s. It is known that he possesses it.
At this exhibition, Heavy Bio plans to introduce a variety of in vitro diagnostic raw materials supplied by the company, promote its extensive business capabilities, and focus on attracting new customers. In addition, prototype products such as Uncut Sheet and Bulk Reagents for CLIA are also planned to be exhibited.
A Heavy Bio official said, “We also provide a variety of technical services to our customers, including validation and evaluation of IVD kits, product registration, and establishment of a quality system for production and operation.” He added, “In this way, our customers are involved in the research and development and production process. “We are committed to helping you save time and money, and providing convenient technical support.”
He continued, “After entering the domestic market in earnest in 2022, we have already secured 9 business partners, and we have proven our excellent capabilities early on with visible results, such as helping a customer’s in vitro diagnostic kit using our raw materials obtain in vitro approval from the Ministry of Food and Drug Safety. did. “By making this known again at this exhibition, we hope to further strengthen our presence in the domestic industry.”
Meanwhile, the main exhibition items of ‘KOAMEX 2023’ hosted by Daegu Metropolitan City and K-MEDI Hub are as follows. △Diagnostic and diagnostic devices such as scanners, measuring devices, and imaging devices △Clinical and inspection devices △Surgical and recycling devices △Hospital facilities and emergency equipment △Medical devices, parts, and services △Pharmaceutical devices △Medical services, SW